Surgery To Treat Rectal Cancer. Part 2 of 3

So “From my experience, most patients are game to accept some risk to defer rectal surgery in hope of avoiding major surgery and preserving rectal function,” said Paty, a surgical oncologist at the Memorial Sloan-Kettering Cancer Center in New York City. The findings are to be presented Monday at the Gastrointestinal Cancers Symposium in San Francisco. ASCO is one of four organizations sponsoring the symposium. Research presented at medical meetings should be viewed as prior until published in a peer-reviewed journal.

The swat authors said that the type of patients who would most likely do well without immediate surgery are the up to 50 percent of stage I patients whose tumors typically evanish altogether following initial chemotherapy/radiation treatment. That figure hovers at between 30 percent and 40 percent among stage II and III patients. The rejuvenated investigation looked at the experience of rectal cancer patients who were treated between 2006 and 2014 at Memorial Sloan-Kettering.

Parts: 1 2 3